Table 3 Correlation analysis of Caveolin-1 expression with clinical and pathological variables in primary breast cancer patients. Included are only cases in both Caveolin-1 expression status as well as clinical and pathological variable were available
From: Caveolin-1 expression in benign and malignant lesions of the breast
clinical and pathological variables | Caveolin-1 positive/all tumours (%) | p (χ2-test) | |
|---|---|---|---|
ER | negative | 15/41 (36.6) | 0.204 |
positive | 16/64 (25.0) | ||
PR | negative | 20/65 (30.8) | 0.721 |
positive | 11/40 (55.0) | ||
HER2 | negative | 28/98 (28.6) | 0.320 |
positive | 4/9 (44.4) | ||
Mib1 | < 20% | 15/39 (38.4) | 0.143 |
≥ 20% | 17/68 (25.0) | ||
pT-stage | T1/2 | 22/80 (27.5) | 0.476 |
T3/4 | 10/29 (34.5) | ||
pN-stage | negative | 18/60 (30.0) | 0.981 |
positive | 14/47 (29.8) | ||
pM-stage | negative | 29/94 (30.9) | 0.391 |
positive | 3/15 (20.0) | ||
tumour grade | 1 | 1/6 (16.7) | 0.740 |
2 | 17/59 (28.8) | ||
3 | 14/44 (31.8) | ||
multifocality | no | 19/83 (22.9) | 0.008 |
yes | 13/26 (50.0) | ||
inflammatory | no | 30/102 (29.4) | 0.962 |
yes | 2/7 (28.6) | ||
lymphangiosis carcinomatosa | no | 22/82 (26.8) | 0.312 |
yes | 10/27 (37.0) |